Please assess the completion status of the following clinical trial:

Trial Title: Study on the Use of Micropulse Laser to Treat Central Serous Chorioretinopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with new diagnosis of CSC and no other comorbidities or prior retinal treatment~* Patients ranging from 30 to 60 years of age~Exclusion Criteria:~* Patients with no case of CSC~* Patients with other macular comorbidities including but not limited to diabetic retinopathy, macular degeneration~* Patients with prior retinal treatment

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 60 Years
- Healthy Volunteers: f

Study Arms:
- Micropulse Laser Treatment (Type: EXPERIMENTAL): Patient's randomized to ML treatment would be treated with the following settings: 200 micron spot size, 0.2 second duration, 15% duty cycle, and 300 milliWatt power. Their eyes would be dilated prior to treatment with standard mydriatic medications, including Tropicamide and Phenylephrine
- No Treatment (Type: PLACEBO_COMPARATOR): Patients randomized to this treatment arm, will not receive treatment for CSC. They will continue to be observed at month 1 and month 3. If any worsening of pathology is found during the follow up visits, the patient will be removed from the study and given appropriate standard of care by the attending

Based on this trial design, predict the completion outcome and termination type (if applicable).